Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.3 USD | -4.02% | -10.06% | +51.47% |
Apr. 01 | Solid Biosciences' SGT-003 Receives US FDA's Rare Pediatric Disease Label | MT |
Apr. 01 | Solid Biosciences Gets FDA Rare-Pediatric Designation for SGT-003 in Duchenne | DJ |
Financials (USD)
Sales 2024 * | 3.52M | Sales 2025 * | 5.32M | Capitalization | 352M |
---|---|---|---|---|---|
Net income 2024 * | -103M | Net income 2025 * | -124M | EV / Sales 2024 * | 57.4 x |
Net cash position 2024 * | 150M | Net cash position 2025 * | 67.4M | EV / Sales 2025 * | 53.5 x |
P/E ratio 2024 * |
-3.35
x | P/E ratio 2025 * |
-3.42
x | Employees | 88 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 80.91% |
Latest transcript on Solid Biosciences Inc.
1 day | -4.02% | ||
1 week | -10.06% | ||
Current month | +4.85% | ||
1 month | -5.30% | ||
3 months | -7.19% | ||
6 months | +241.91% | ||
Current year | +51.47% |
Managers | Title | Age | Since |
---|---|---|---|
Annie Ganot
FOU | Founder | - | 13-02-28 |
Ilan Ganot
FOU | Founder | 50 | 13-02-28 |
Alexander Cumbo
CEO | Chief Executive Officer | 53 | 22-09-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ian Smith
CHM | Chairman | 58 | 20-04-14 |
Martin Freed
BRD | Director/Board Member | 63 | 18-06-25 |
Raj Shah
BRD | Director/Board Member | 46 | 17-02-28 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-16 | 9.3 | -4.02% | 200,335 |
24-05-15 | 9.69 | -2.71% | 68,343 |
24-05-14 | 9.96 | +2.15% | 92,291 |
24-05-13 | 9.75 | -6.16% | 163,043 |
24-05-10 | 10.39 | +0.48% | 175,420 |
Delayed Quote Nasdaq, May 16, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+51.47% | 352M | |
+8.29% | 114B | |
+10.21% | 104B | |
+0.41% | 22.28B | |
-11.90% | 22.41B | |
-5.99% | 19.07B | |
-37.36% | 18B | |
-5.17% | 17.89B | |
+7.70% | 14.28B | |
+37.65% | 12.55B |
- Stock Market
- Equities
- SLDB Stock